Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus
Author
dc.contributor.author
González Gronow, Mario
Author
dc.contributor.author
Cuchacovich Turteltaub, Miguel
Author
dc.contributor.author
Francos, Rina
Author
dc.contributor.author
Cuchacovich, Stephanie
Author
dc.contributor.author
Blanco, Ángel
Author
dc.contributor.author
Sandoval, Rodrigo
Author
dc.contributor.author
Farías Gómez, Cristian
Author
dc.contributor.author
Valenzuela, Javier
Author
dc.contributor.author
Ray, Rupa
Author
dc.contributor.author
Pizzo, Salvatore
Admission date
dc.date.accessioned
2015-12-18T13:26:36Z
Available date
dc.date.available
2015-12-18T13:26:36Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Journal of Neuroimmunology 287 (2015) 1–8
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.jneuroim.2015.07.006
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/135841
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Autoantibodies from autistic spectrum disorder (ASD) patients react with multiple proteins expressed in the
brain. One such autoantibody targets myelin basic protein (MBP). ASD patients have autoantibodies to MBP of
both the IgG and IgA classes in high titers, but no autoantibodies of the IgMclass. IgA autoantibodies act as serine
proteinases and degradeMBP in vitro. They also induce a decrease in long-termpotentiation in the hippocampi of
rats either perfusedwith or previously inoculated with this IgA. Because this class of autoantibody causes myelin
sheath destruction in multiple sclerosis (MS), we hypothesized a similar pathological role for them in ASD.
Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus